| Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells. | colorectal,breast, |
| [Methylation status of c-fms oncogene in hepatocellular carcinoma and its relation with clinical pathology]. | liver, |
| Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology. | liver, |
| c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms. | colorectal, |
| Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element. | breast, |
| The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma. | liver, |
| Expression of the colony-stimulating factor-1 receptor (c-fms proto-oncogene product) in the human uterus and placenta. | colorectal, |
| Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis. | breast, |
| Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice. | colorectal, |
| Transforming mechanism of the feline sarcoma virus encoded v-fms oncogene product. | sarcoma, |
| Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer. | breast, |
| Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer. | breast, |
| Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells. | breast, |
| Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells. | breast, |
| Expression of proto-oncogene cFMS protein in lung, breast, and ovarian cancers. | breast,ovarian,lung, |
| Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging. | breast, |
| Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells. | leukemia, |
| Detection of fms-oncogene-specific tyrosine kinase activity in human leukemia cells. | leukemia, |
| The colony-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand. | colorectal, |
| Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene. | colorectal, |